| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/24/2005 | US20050066388 Using site specific transformation to generate insect resistant plants; genetic engineering and biological pest control |
| 03/24/2005 | US20050066387 Rice glutelin gene promoters |
| 03/24/2005 | US20050066386 Expression vector comprising upstream/downstream plant regulatory element for use as tool in efficient transfer of homologous sequence into plants, homologous recombination and allelic transfer; gene function analysis |
| 03/24/2005 | US20050066385 Using expression vector comprising nucleotide sequences coding agamous-like-42 gene sequences(AGL42) for use as tool in the regulation and/or maintenance and/or promotion of root growth and stability |
| 03/24/2005 | US20050066384 Using plasmid to enhance site-specific and/or homologous recombination between heterologous gene sequences and host nuclear DNA; tissue engineering and exogenous gene expression in plants |
| 03/24/2005 | US20050066383 Using homologous/site specific recombination to generate transgenic poultry; bioreactors for antibody production; vaccine development |
| 03/24/2005 | US20050066382 Replication-defective retroviral vector for use as gene transfer and expression tool in avian transgenics; bioreactor and heterologous protein expression; tissue engineering |
| 03/24/2005 | US20050066381 Transgenic mouse comprising modified gene sequences associated with protein kinase c expression for use as tool in identifying modulator for treatment and prevention of cardiovascular and cardiomyopathic disorders |
| 03/24/2005 | US20050066380 Perv screening method and use thereof |
| 03/24/2005 | US20050066379 Preparing somatic embryo by utilizing rabbit oocyte |
| 03/24/2005 | US20050066378 Transgenic animal comprising gene which induces lymphoproliferation for use as tool in generating autoantibodies for detection and treatment of autoimmune diseases; immunotherapy |
| 03/24/2005 | US20050066377 Library of preferential gene sequences stored in solid support matrices for use as high throughput tools in genomic analysis; gene therapy |
| 03/24/2005 | US20050066376 Genetic manipulation method |
| 03/24/2005 | US20050066375 Genetic engineered rodent comprising gene sequences coding antigenic recognition and/or cell activation of T cell polypeptide for use in treatment and prevention of infection, viral, nervous system and inflammatory diseases |
| 03/24/2005 | US20050065737 genotypically and phenotypically characterizing a sample of a population |
| 03/24/2005 | US20050065334 Novel human proteases and polynucleotides encoding the same |
| 03/24/2005 | US20050065333 Breast cancer-associated genes and uses thereof |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065320 Mutated env gene, mutated env glycoprotein and the use thereof |
| 03/24/2005 | US20050065107 Plasmids suitable for IL-2 expression |
| 03/24/2005 | US20050065104 therapy of atherosclerosis; cardiovascular disorders |
| 03/24/2005 | US20050065103 Phosphorothioate antisense heparanase oligonucleotides |
| 03/24/2005 | US20050065102 Medicinal compositions |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050065079 Therapy for metabolism disorders ; obesity; antilipemic agents; atherosclerosis; hypotensive agents; antidiabetic agents |
| 03/24/2005 | US20050065065 Modulation of the expression of estrogen receptors for the prevention or treatment of heart disease |
| 03/24/2005 | US20050064596 Buffer solution for electroporation and a method comprising the use of the same |
| 03/24/2005 | US20050064595 Silencing gene expression by delivering nucleic acid-lipid particles comprising a siRNA molecule to a cell; stable nucleic acid-lipid particles (SNALP) |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064578 Multicompartment apparatus for use in transfection of nucleic acids into cells; electrofusion; electroporation |
| 03/24/2005 | US20050064574 Expression vector comprising nucleotide sequences coding lytic enzyme for use as gene transfer tool in generating transgenic lactobacillus with enhanced amylase activity; improving digestibility of animal feeds |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064570 Whole cell catalyst which expresses lactobacillus oxidase for use in generating/producing chrial enantiomer-enriched organic compounds |
| 03/24/2005 | US20050064569 Enzymatic polypeptide which is functionally active in presence of ethyl 4-chloroacetoacetate for use in regenerating coenzymes in an enzymatic reduction system; cyclic generation of preferential compounds |
| 03/24/2005 | US20050064565 Polyhydroxybutyrate polymerase |
| 03/24/2005 | US20050064563 Nucleotide sequences coding gene cluster assoiated with biosynthesis of coumermycin for use as tool in prevention and treatment of infection and cell proliferative disorders |
| 03/24/2005 | US20050064559 Beta1,3-galactosyltransferase and DNA encoding the same |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064557 Method for producing proteins |
| 03/24/2005 | US20050064556 Transforming yeast cell with expression vector expressing gene coding tissue factor pathway inhibitor (TFPI) and tissue factor pathway inhibitor-2 (TFPI-2) for use as tool in treatment and prevention of thrombosis; bioreactors |
| 03/24/2005 | US20050064554 Canine GHRH gene, polypeptides and methods of use |
| 03/24/2005 | US20050064553 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 03/24/2005 | US20050064552 Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
| 03/24/2005 | US20050064550 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. Jejuni |
| 03/24/2005 | US20050064548 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 03/24/2005 | US20050064547 Vectors and transfected cells |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064545 Transforming prokaryotic cells with expression vector comprising chaperone protein nucleotide sequences; identifying modulators for treatment and prevention of prion and neurodegenerative disorders |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064542 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064527 Identifying modulator of activity of newly identified multiple antibiotic resistance (mar) locus regulated (NIMR) gene products; microbiocides; bactericides |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064512 Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 03/24/2005 | US20050064509 Use of templated self assembly to create novel multifunctional species |
| 03/24/2005 | US20050064496 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders; antisense agents; gene expression inhibition |
| 03/24/2005 | US20050064495 Genetic typing of the human cytochrome P450 2A6 gene and related methods |
| 03/24/2005 | US20050064494 Chemically modified biological molecules and methods for coupling biological molecules to solid support |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064489 Recombinant regulatory sequence for use as tool for controlling heterologous gene expression; genetic engineering and gene therapy; drug screening; RNA interference and gene expression inhibition |
| 03/24/2005 | US20050064487 Using solid support to amplify preferential nucleotide sequences; screening for genetic polymorphisms and aberrations |
| 03/24/2005 | US20050064486 Novel genome analyzing method |
| 03/24/2005 | US20050064484 Method for design support of functional nucleic acids |
| 03/24/2005 | US20050064477 Using polypeptide comprising two Cys2His2 zinc fingers domains as tool in detecting DNA/protein interactions; bioassays |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064474 Cleaving cellular chromatin and inserting expression vector comprising nucleotide sequences coding zinc finger-cleavage half domain genetic exchange; genome engineering and homologous recombination |
| 03/24/2005 | US20050064469 Reaction vessel for carrying out array processes |
| 03/24/2005 | US20050064468 concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports |
| 03/24/2005 | US20050064467 Expression vector comprising scaffold/matrix attached region (S/MAR), an origin of replication (ORI) and one replication initiation factor for use as tool in transfer and expression of heterologous nucleotide sequences; biodrugs |
| 03/24/2005 | US20050064466 Novel human 7TM proteins and polynucleotides encoding the same |
| 03/24/2005 | US20050064465 Using bioreactor comprising RNA polymerase, gene transcription mixture and immobilized templates to generate preferential RNA species; high throughput assay and genic analysis |
| 03/24/2005 | US20050064464 Optimization of immunomodulatory properties of genetic vaccines |
| 03/24/2005 | US20050064463 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 03/24/2005 | US20050064460 Emulsion compositions |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064456 Preparing preferential nucleotide sequences comprising hybridizing first and second oligonucleotides to non-overlapping portions of target sequences, extending and attaching oligonucleotides using RNA primer, cleaving primer, recover sequences |
| 03/24/2005 | US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics |
| 03/24/2005 | US20050064447 Probiotic therapy of neonatal meningitis and method of using E. coli virulence determinatns |
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064444 Oligonucleotide for use in simultaneous and specific detection of legionella, fecal streptococci and coliform bacteria in drinking and surface water |
| 03/24/2005 | US20050064443 Production of functional proteins: balance of shear stress and gravity |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064439 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 03/24/2005 | US20050064433 Method for cloning and expression of sbfi restriction endonuclease and sbfi methylase in e.coli |
| 03/24/2005 | US20050064426 Utilizing probe dependent coefficients to re-scale and correct hybridization data; enhancing accuracy of measured gene expression levels |
| 03/24/2005 | US20050064425 Using overlapping and non-overlapping gene expression profiles as tool in detecting transcriptional units of novel function |
| 03/24/2005 | US20050064421 Generating microarrays comprising immobilized gene sequences from cells associated with immune response; characterizing transcription units associated stimulated lymphocytes |
| 03/24/2005 | US20050064420 Expression vector comprising nucleotide sequences coding estrogen response element for use as regulatory tool in heterologous gene expression |
| 03/24/2005 | US20050064418 Using sequence data to predict and characterize cistrons in microorganisms |
| 03/24/2005 | US20050064417 Methods and compositions to evaluate antibody treatment response |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064415 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna |
| 03/24/2005 | US20050064413 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem |